Group 3: Control: Clinical Trials

2 trials of Group 3: Control, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Not yet recruiting 1
Phase 31Completed 1

Follow Group 3: Control: new trials by email Literature Review of Group 3: Control trials Research Report on Group 3: Control

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Two Types of Calcium (Ca²⁺) Ionophore Treatments for Oocyte Activation in Cases of Suboptimal Fertilization Potential
Group 1: Oocyte Activation (OA) CultActive, Group 2: Oocyte Activation (OA) Ionomycin, Group 3: Control - ICSI, Testicular Sperm Extraction in Azoospermic Patients
Not applicableNot yet recruitingART Fertility Clinics LLC202026-04-302026-05-11
Clinical Trial to Assess the Effect of Testosterone in Patients With Poor Ovarian Response (TESTOPRIM)
GROUP 1: Long testosterone, GROUP 2: Short testosterone, GROUP 3: Control - Infertility, Female
Phase 3CompletedInstituto de Investigacion Sanitaria La Fe632017-08-072019-08-13

Conditions studied

Infertility, Female (1)  ·  Infertility, Male (1)

Sponsors

ART Fertility Clinics LLC (1)  ·  Instituto de Investigacion Sanitaria La Fe (1)

Countries

Spain (1)

Results publications

PMID 12215343, PMID 18983750, PMID 22417664, PMID 25596904, PMID 25602996, PMID 26277587, PMID 26346057, PMID 26658129, PMID 27278231, PMID 27734719, PMID 29108881, PMID 29392515, PMID 29606300, PMID 29620419, PMID 30826994, PMID 31133387, PMID 31709844, PMID 31710194, PMID 31994001, PMID 32285298, PMID 32298520, PMID 35261925, PMID 37747409, PMID 39704318